Congratulations to Dr. Jerry Simecka, for his award from Tetraphase Pharmaceuticals, Inc , in the amount of $28,619, for “TetraPhase 2018-01: TP-6076 single dose pharmacokinetic study for ex vivo plasma protein binding.”
For more details, view the latest Monthly Research Report on our site, linked above.